KEZAR LIFE SCIENCES, INC.

Analyst Reco. Kezar Life Sciences, Inc.

Equities

KZR

US49372L1008

Delayed Nasdaq Other stock markets 20:56:40 02/05/2024 BST			5-day change	1st Jan Change
0.8585 ^USD	+2.39%		+8.62%	-9.43%

03-14	Kezar Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-14	Kezar Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wells Fargo Adjusts Price Target on Kezar Life Sciences to $2 From $4, Maintains Equal-Weight Rating	11-14	MT
JonesTrading Downgrades Kezar Life Sciences to Hold From Buy	05/10/23	MT
HC Wainwright Raises Kezar Life Sciences Price Target to $20 From $18, Maintains Buy Rating	25/09/23	MT
Wells Fargo Downgrades Kezar Life Sciences to Equalweight From Overweight	11/08/23	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $18 From $19, Maintains Buy Rating	11/08/23	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $19 From $21, Keeps Buy Rating	12/05/23	MT
Wells Fargo Trims Kezar Life Sciences Price Target to $13 From $14, Maintains Overweight Rating	12/05/23	MT
William Blair Downgrades Kezar Life Sciences to Market Perform From Outperform	16/03/23	MT
Wells Fargo Cuts Price Target on Kezar Life Sciences to $14 From $17, Maintains Overweight Rating	03/01/23	MT
Wells Fargo Adjusts Kezar Life Sciences Price Target to $17 From $13, Maintains Overweight Rating	28/06/22	MT
Wells Fargo Adjusts Kezar Life Sciences' Price Target to $14 from $19, Keeps Overweight Rating	04/05/22	MT
Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services Index	04/05/22	MT
HC Wainwright Adjusts Kezar Life Sciences' Price Target to $22 From $20, Keeps Buy Rating	18/03/22	MT
Wells Fargo Starts Kezar Life Sciences at Overweight With $19 Price Target	08/12/21	MT
HC Wainwright Adjusts Price Target on Kezar Life Sciences to $20 from $12, Keeps Buy Rating	16/11/21	MT
KEZAR LIFE SCIENCES : JonesTrading Starts Kezar Life Sciences at Buy With $14 Price Target	20/07/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer